跳至主要内容
临床试验/NCT00087750
NCT00087750Unknown1 期

Interaction Between IV Cocaine and Quetiapine

National Institute on Drug Abuse (NIDA)2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2003年10月最近更新:
适应症
相关药物

试验速览

阶段
1 期
入组人数
12
试验地点
2
主要终点
pharmacokinetic assessment

研究概览

简要总结

The purpose of this study is to assess the safety of intravenous (IV) cocaine in subjects taking quetiapine at 3 dosage levels.

详细描述

A placebo-controlled, double-blind, inpatient assessment of interaction between intravenous cocaine and quetiapine (seroquel) in cocaine-experienced subjects. To assess the safety of IV cocaine in subjects taking quetiapine at 3 dosage levels.

研究设计

研究类型
Interventional
分配方式
Randomized
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Includes but is not limited to: non-treatment seeking individuals. Must meet DSM-IV criteria for cocaine abuse or dependence. Must be able to verbalize understanding of consent and provide written informed consent and verbalize willingness to complete study procedures. Site will provide further details.

排除标准

  • Please contact site for further information

结局指标

主要结局

pharmacokinetic assessment

Adverse events

次要结局

未报告次要终点

研究者

申办方类型
Nih

研究点 (2)

Loading locations...

相似试验

Interaction Between Cocaine and Quetiapine - 1 | 临床试验